| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.059 | 0.7 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |